115 related articles for article (PubMed ID: 23939157)
1. [Expressions of CMTM8 and E-cadherin in primary and metastatic clear cell renal cell carcinoma].
Hu H; Chen JW; Xu KX; Wang D; Wang Y; Wang GW; Zhang SY; Wang XF
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Aug; 45(4):537-41. PubMed ID: 23939157
[TBL] [Abstract][Full Text] [Related]
2. CMTM8 is Frequently Downregulated in Multiple Solid Tumors.
Zhang W; Qi H; Mo X; Sun Q; Li T; Song Q; Xu K; Hu H; Ma D; Wang Y
Appl Immunohistochem Mol Morphol; 2017 Feb; 25(2):122-128. PubMed ID: 26574634
[TBL] [Abstract][Full Text] [Related]
3. [Expression and clinical significance of kidney injury molecule-1 in renal epithelial neoplasms].
Dong YC; Wu B; Wang JD; Rao Q; Ma HH; Zhang RS; Zhou HB; Lu ZF; Zhou XJ
Zhonghua Bing Li Xue Za Zhi; 2010 Jan; 39(1):35-9. PubMed ID: 20388397
[TBL] [Abstract][Full Text] [Related]
4. [E-cadherin expression and histopathological features in renal cell carcinomas].
Jin TX; Kakehi Y; Moroi S; Yoshida O
Hinyokika Kiyo; 1995 Sep; 41(9):653-7. PubMed ID: 7484527
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization of the tumor suppressor CMTM8 and its association with prognosis in bladder cancer.
Zhang S; Pei X; Hu H; Zhang W; Mo X; Song Q; Zhang Y; Xu K; Wang Y; Na Y
Tumour Biol; 2016 May; 37(5):6217-25. PubMed ID: 26615421
[TBL] [Abstract][Full Text] [Related]
6. [Expression of Ksp-cadherin in renal epithelial neoplasm and its clinicopathologic significance].
Rao Q; Zhou XJ; Shi QL; Yin HL; Ma HH; Zhou HB; Zhang RS
Zhonghua Bing Li Xue Za Zhi; 2007 Jan; 36(1):15-8. PubMed ID: 17374232
[TBL] [Abstract][Full Text] [Related]
7. Research Advances in Chemokine-like Factor Super Family Member 8.
Gao DH; Hu H; Fang ZW; Huo F; Wang HR; Xu KX; Wang XF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Dec; 38(6):746-749. PubMed ID: 28065246
[TBL] [Abstract][Full Text] [Related]
8. CMTM8 Is a Suppressor of Human Mesenchymal Stem Cell Osteogenic Differentiation and Promoter of Proliferation Via EGFR Signaling.
H'ng CH; Camp E; Anderson PJ; Zannettino ACW; Gronthos S
Stem Cells Dev; 2020 Jul; 29(13):823-834. PubMed ID: 32268840
[TBL] [Abstract][Full Text] [Related]
9. [Low expressions of EHD2 and E-cadherin correlate with a poor prognosis for clear cell renal cell carcinoma].
Ye M; Fan G; Zhu S; Han W; Xie Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Aug; 44(8):864-870. PubMed ID: 31570672
[TBL] [Abstract][Full Text] [Related]
10. CMTM8 inhibits the carcinogenesis and progression of bladder cancer.
Gao D; Hu H; Wang Y; Yu W; Zhou J; Wang X; Wang W; Zhou C; Xu K
Oncol Rep; 2015 Dec; 34(6):2853-63. PubMed ID: 26503336
[TBL] [Abstract][Full Text] [Related]
11. Reduced expression of E-cadherin and increased sialylation level in clear cell renal cell carcinoma.
Borzym-Kluczyk M; Radziejewska I; Cechowska-Pasko M; Darewicz B
Acta Biochim Pol; 2017; 64(3):465-470. PubMed ID: 28742884
[TBL] [Abstract][Full Text] [Related]
12. [Expression of LIM and SH3 protein 1 in renal clear cell carcinoma and its effects on invasion and migration of renal clear cell carcinoma 786-O cells].
Jin B; Gao L; Li W; Chen JC; Wen RM; Wang JQ
Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):166-171. PubMed ID: 28316213
[No Abstract] [Full Text] [Related]
13. Downregulated CMTM8 Correlates with Poor Prognosis in Gastric Cancer Patients.
Yan M; Zhu X; Qiao H; Zhang H; Xie W; Cai J
DNA Cell Biol; 2021 Jun; 40(6):791-797. PubMed ID: 33978454
[TBL] [Abstract][Full Text] [Related]
14. CMTM3 (CKLF-Like Marvel Transmembrane Domain 3) Mediates Angiogenesis by Regulating Cell Surface Availability of VE-Cadherin in Endothelial Adherens Junctions.
Chrifi I; Louzao-Martinez L; Brandt M; van Dijk CGM; Burgisser P; Zhu C; Kros JM; Duncker DJ; Cheng C
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1098-1114. PubMed ID: 28428220
[TBL] [Abstract][Full Text] [Related]
15. The utility of tetraspanin CD9 as a biomarker for metastatic clear cell renal cell carcinoma.
Garner JM; Herr MJ; Hodges KB; Jennings LK
Biochem Biophys Res Commun; 2016 Feb; 471(1):21-5. PubMed ID: 26855131
[TBL] [Abstract][Full Text] [Related]
16. Genetic changes of the E-cadherin and APC tumour suppressor genes in clear cell renal cell carcinoma.
Pećina-SLaus N; Gall-TroSelj K; SLaus M; Radić K; NikuSeva-Martić T; Pavelić K
Pathology; 2004 Apr; 36(2):145-51. PubMed ID: 15203750
[TBL] [Abstract][Full Text] [Related]
17. Influence of CMTM8 polymorphisms on lung cancer susceptibility in the Chinese Han population.
Wu J; Sun Y; Xiong Z; Niu F; Liu Y; Li H; Liu J; Wu J; Liu Q; Jin T
Pharmacogenet Genomics; 2021 Jun; 31(4):89-95. PubMed ID: 33395025
[TBL] [Abstract][Full Text] [Related]
18. Unmethylated E-cadherin gene expression is significantly associated with metastatic human prostate cancer cells in bone.
Saha B; Kaur P; Tsao-Wei D; Naritoku WY; Groshen S; Datar RH; Jones LW; Imam SA
Prostate; 2008 Nov; 68(15):1681-8. PubMed ID: 18712716
[TBL] [Abstract][Full Text] [Related]
19. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB
Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
[TBL] [Abstract][Full Text] [Related]
20. Low-grade metastases in high-grade clear cell renal cell carcinomas: A clinicopathologic study of 4 cases with an insight into the role of mesenchymal-to-epithelial transition process.
López JI; Mosteiro L; Guarch R; Larrinaga G; Pulido R; Angulo JC
Ann Diagn Pathol; 2016 Feb; 20():13-8. PubMed ID: 26616721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
